Laboratory studies with BL-S 578 (Cefadroxil) a new broad-spectrum orally active cephalosporin.

Cefadroxil, a new broad-spectrum cephalosporin.

Deferitazole, a new orally active iron chelator.

Pharmacologic studies with cefaclor, a new oral cephalosporin.

In vitro studies with cefaclor, a new oral cephalosporin.

Studies with cefuroxime: a new beta-lactamase resistant cephalosporin.

Laboratory evaluation of FR10024 a new cephalosporin derivative.

Oxanilic acids, a new series of orally active antiallergic agents.

BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies.

In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.

Cefazaflur, a new parenteral cephalosporin: in vitro studies.

Exploratory Studies With BT-11: A Proposed Orally Active Therapeutic for Crohn's Disease.

Laboratory studies with a new broad-spectrum penicillin, pirbenicillin.

Volunteer and clinical studies with carfecillin: a new orally administered ester of carbenicillin.

In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.

A new cephalosporin with a dual mode of action.

HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.

Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin.

[Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension].

The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen.

trans-2,3b,4,5,7,8b,9,10-Octahydronaphtho[1,2-c:5,6-c']dipyrazole, a new orally active antiallergic compound.

In vitro and clinical studies of cefatrizine, a new semisynthetic cephalosporin.

In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporin.

Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity.

In vitro and in vivo studies of ME1228, a new parenteral cephalosporin with potent activity against Pseudomonas aeruginosa.

Suggest Documents

Cefadroxil, a new broad-spectrum cephalosporin.

Deferitazole, a new orally active iron chelator.

Pharmacologic studies with cefaclor, a new oral cephalosporin.

In vitro studies with cefaclor, a new oral cephalosporin.

Studies with cefuroxime: a new beta-lactamase resistant cephalosporin.

Laboratory evaluation of FR10024 a new cephalosporin derivative.

Oxanilic acids, a new series of orally active antiallergic agents.

BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies.

In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.

Cefazaflur, a new parenteral cephalosporin: in vitro studies.

Exploratory Studies With BT-11: A Proposed Orally Active Therapeutic for Crohn's Disease.

Laboratory studies with a new broad-spectrum penicillin, pirbenicillin.

Volunteer and clinical studies with carfecillin: a new orally administered ester of carbenicillin.

In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.

A new cephalosporin with a dual mode of action.

HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.

Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin.

[Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension].

The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen.

trans-2,3b,4,5,7,8b,9,10-Octahydronaphtho[1,2-c:5,6-c']dipyrazole, a new orally active antiallergic compound.

In vitro and clinical studies of cefatrizine, a new semisynthetic cephalosporin.

In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporin.

Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity.

In vitro and in vivo studies of ME1228, a new parenteral cephalosporin with potent activity against Pseudomonas aeruginosa.

Laboratory studies with BL-S 578 (Cefadroxil) a new broad-spectrum orally active cephalosporin.

Recommend Documents

Follow Us